Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study

AIMS: Dipeptidyl peptidase-4, a transmembrane glycoprotein expressed in various cell types, serves as a co-stimulator molecule to influence immune response. This study aimed to investigate associations between DPP-4 inhibitors and risk of autoimmune disorders in patients with type 2 diabetes mellitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Chuan, Chen, Tien-Hsing, Sun, Chi-Chin, Chen, Jau-Yuan, Chang, Shy-Shin, Yeung, Ling, Tsai, Yi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173685/
https://www.ncbi.nlm.nih.gov/pubmed/32318876
http://dx.doi.org/10.1007/s00592-020-01533-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173685/
https://www.ncbi.nlm.nih.gov/pubmed/32318876
http://dx.doi.org/10.1007/s00592-020-01533-5

Ejemplares similares